Outcomes of chronic myeloid leukemia (CML) patients who stopped second generation tyrosine kinase inhibitors (2GTKIS) as second line treatment. results of the CML Spanish National Registry (RELMC)
Services
Services
Date issued
2012Journal title
Blood
Type of content
Publicación de congreso
